Terms: = Ovarian cancer AND ZNF198, Q9UBW7, SCLL, RAMP, MYM, FIM, 7750 AND Prognosis
4 results:
1. Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.
Kang OJ; Lee SW; Kim JH; Park JY; Suh DS; Kim DY; Kim JH; Kim YM; Kim YT
Int J Gynecol Cancer; 2023 Nov; 33(11):1743-1749. PubMed ID: 37541685
[TBL] [Abstract] [Full Text] [Related]
2. Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer.
Nomura H; Ikki A; Fusegi A; Omi M; Aoki Y; Netsu S; Tanigawa T; Matoda M; Okamoto S; Omatsu K; Nakajima T; Ueki A; Tonooka A; Kanao H
Int J Clin Oncol; 2021 Dec; 26(12):2331-2337. PubMed ID: 34453642
[TBL] [Abstract] [Full Text] [Related]
3. [Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum].
Škapa P; Dundr P
Cesk Patol; 2016; 52(4):199-204. PubMed ID: 27869446
[TBL] [Abstract] [Full Text] [Related]
4. Inpatient rehabilitation performance of patients with paraneoplastic cerebellar degeneration.
Fu JB; Raj VS; Asher A; Lee J; Guo Y; Konzen BS; Bruera E
Arch Phys Med Rehabil; 2014 Dec; 95(12):2496-9. PubMed ID: 25051460
[TBL] [Abstract] [Full Text] [Related]
